Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Mondelez International
MDLZ
$78.8B
| $81.8M | 0.08% |
1,172,932
-96,685
| -8% | -$6.4M |
|
127
Edison International
EIX
$27.5B
| $80.8M | 0.07% |
1,144,618
| – | – |
|
128
Amgen
AMGN
$204B
| $80.4M | 0.07% |
332,426
+6,768
| +2% | +$1.66M |
|
129
Paycom
PAYC
$7.86B
| $80.1M | 0.07% |
263,397
+53,181
| +25% | +$16M |
|
130
Kirby Corp
KEX
$6.98B
| $79.8M | 0.07% |
1,145,535
+102,839
| +10% | +$7.08M |
|
|
ENLC
131
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $79.7M | 0.07% |
7,352,628
+3,207,528
| +77% | +$38M |
|
132
GFL Environmental
GFL
$15.2B
| $79.2M | 0.07% |
2,299,136
-273,610
| -11% | -$8.63M |
|
133
Bloomin' Brands
BLMN
$774M
| $76.8M | 0.07% |
2,992,903
+33,074
| +1% | +$822K |
|
134
Molina Healthcare
MOH
$10.2B
| $76.8M | 0.07% |
286,969
+25,030
| +10% | +$7.19M |
|
135
Littelfuse
LFUS
$11.3B
| $75.9M | 0.07% |
283,207
-9,744
| -3% | -$2.5M |
|
136
Parker-Hannifin
PH
$126B
| $75.2M | 0.07% |
223,725
+199,748
| +833% | +$66.1M |
|
137
KBR
KBR
$4.68B
| $74.5M | 0.07% |
1,353,150
+45,652
| +3% | +$2.39M |
|
138
Acadia Healthcare
ACHC
$2.85B
| $74.4M | 0.07% |
1,029,479
+63,031
| +7% | +$4.91M |
|
139
Pinnacle West Capital
PNW
$12.2B
| $74.3M | 0.07% |
+937,625
| New | +$70.7M |
|
140
Xcel Energy
XEL
$48.5B
| $73.9M | 0.07% |
1,096,335
+7,639
| +0.7% | +$515K |
|
|
SUM
141
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $73.5M | 0.07% |
2,579,709
-407,221
| -14% | -$12.3M |
|
142
Truist Financial
TFC
$63.4B
| $72.7M | 0.07% |
2,132,526
-1,242,767
| -37% | -$54.3M |
|
143
WillScot Mobile Mini Holdings
WSC
$4.66B
| $72.6M | 0.07% |
1,548,098
-905,599
| -37% | -$43.6M |
|
144
Huron Consulting
HURN
$2.39B
| $71.4M | 0.07% |
888,348
+30,942
| +4% | +$2.25M |
|
145
AES
AES
$10.5B
| $70.2M | 0.06% |
2,914,848
+833,332
| +40% | +$21.2M |
|
146
Ferrari
RACE
$70.5B
| $70M | 0.06% |
258,419
+3,724
| +1% | +$951K |
|
147
Cigna
CI
$74.5B
| $68.8M | 0.06% |
269,087
-5,054
| -2% | -$1.47M |
|
148
Nu Holdings
NU
$69.8B
| $68M | 0.06% |
14,287,112
-63,703,433
| -82% | -$284M |
|
149
Zoetis
ZTS
$32.3B
| $67M | 0.06% |
402,529
-204,451
| -34% | -$33.5M |
|
150
Brunswick
BC
$5.16B
| $66.8M | 0.06% |
814,114
+17,113
| +2% | +$1.42M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.